PortfoliosLab logo
BTAI vs. OPK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BTAI and OPK is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Performance

BTAI vs. OPK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioXcel Therapeutics, Inc. (BTAI) and OPKO Health, Inc. (OPK). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

BTAI:

71.04%

OPK:

42.40%

Max Drawdown

BTAI:

-10.53%

OPK:

-98.17%

Current Drawdown

BTAI:

-10.53%

OPK:

-93.51%

Fundamentals

Market Cap

BTAI:

$8.37M

OPK:

$983.39M

EPS

BTAI:

-$23.51

OPK:

-$0.06

PS Ratio

BTAI:

3.69

OPK:

1.43

PB Ratio

BTAI:

3.97

OPK:

0.75

Total Revenue (TTM)

BTAI:

$1.68M

OPK:

$689.41M

Gross Profit (TTM)

BTAI:

-$380.00K

OPK:

$221.46M

EBITDA (TTM)

BTAI:

-$21.06M

OPK:

$117.70M

Returns By Period


BTAI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

OPK

YTD

-15.65%

1M

-12.37%

6M

-18.42%

1Y

-3.13%

5Y*

-12.64%

10Y*

-22.98%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BTAI vs. OPK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BTAI
The Risk-Adjusted Performance Rank of BTAI is 77
Overall Rank
The Sharpe Ratio Rank of BTAI is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of BTAI is 11
Sortino Ratio Rank
The Omega Ratio Rank of BTAI is 33
Omega Ratio Rank
The Calmar Ratio Rank of BTAI is 11
Calmar Ratio Rank
The Martin Ratio Rank of BTAI is 1515
Martin Ratio Rank

OPK
The Risk-Adjusted Performance Rank of OPK is 4242
Overall Rank
The Sharpe Ratio Rank of OPK is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of OPK is 4141
Sortino Ratio Rank
The Omega Ratio Rank of OPK is 4040
Omega Ratio Rank
The Calmar Ratio Rank of OPK is 4444
Calmar Ratio Rank
The Martin Ratio Rank of OPK is 4040
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BTAI vs. OPK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BioXcel Therapeutics, Inc. (BTAI) and OPKO Health, Inc. (OPK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

BTAI vs. OPK - Dividend Comparison

Neither BTAI nor OPK has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BTAI vs. OPK - Drawdown Comparison

The maximum BTAI drawdown since its inception was -10.53%, smaller than the maximum OPK drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for BTAI and OPK. For additional features, visit the drawdowns tool.


Loading data...

Volatility

BTAI vs. OPK - Volatility Comparison


Loading data...

Financials

BTAI vs. OPK - Financials Comparison

This section allows you to compare key financial metrics between BioXcel Therapeutics, Inc. and OPKO Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20212022202320242025
366.00K
149.95M
(BTAI) Total Revenue
(OPK) Total Revenue
Values in USD except per share items